who introduced antipsychotic chlorpromazine
**Core Concept**
The introduction of chlorpromazine marked a significant milestone in the treatment of psychotic disorders, introducing a new class of antipsychotic medications. Chlorpromazine, a phenothiazine derivative, was the first effective antipsychotic agent, revolutionizing the management of schizophrenia and other psychoses. Its mechanism of action involves blocking dopamine receptors, particularly D2 receptors, in the mesolimbic pathway.
**Why the Correct Answer is Right**
Chlorpromazine was introduced by French chemist Paul Charpentier in 1950, but its psychiatric applications were first explored by French psychiatrist Henri Laborit. Laborit's work led to the first clinical trials of chlorpromazine in psychiatric patients, demonstrating its efficacy in reducing symptoms of psychosis. The discovery of chlorpromazine's antipsychotic properties paved the way for the development of subsequent antipsychotic medications.
**Why Each Wrong Option is Incorrect**
**Option A:** There is no notable figure associated with the introduction of chlorpromazine in the context of antipsychotic medication.
**Option B:** While Henri Laborit was involved in the early clinical trials of chlorpromazine, he was not the one who first introduced the medication.
**Option C:** Paul Charpentier synthesized chlorpromazine, but he was not the one who first recognized its antipsychotic properties.
**Clinical Pearl / High-Yield Fact**
Chlorpromazine was initially used as an anesthetic agent before its antipsychotic properties were discovered. This highlights the importance of careful evaluation of new medications and their potential applications.
**Correct Answer: D. Henri Laborit**